SAYER KEVIN R 4
4 · DEXCOM INC · Filed Mar 11, 2025
Insider Transaction Report
Form 4
DEXCOM INCDXCM
SAYER KEVIN R
DirectorExecutive Chair
Transactions
- Award
Common Stock
2025-03-08+85,490→ 404,527 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. Restricted stock units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Included in this number are 138,091 unvested restricted stock units, 85,490 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 34,461 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 18,140 of which were granted on March 9, 2023 and shall vest through March 8, 2026.